BioAdaptives, Inc.
BDPT
$0.0653
-$0.0147-18.38%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -100.00% | 177.78% | |||
| Gross Profit | 100.00% | -187.08% | |||
| SG&A Expenses | 444.91% | 14.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 176.70% | 61.03% | |||
| Operating Income | -176.70% | -62.53% | |||
| Income Before Tax | -888.83% | 79.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -888.83% | 79.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -888.83% | 79.45% | |||
| EBIT | -176.70% | -62.53% | |||
| EBITDA | -176.70% | -62.53% | |||
| EPS Basic | -495.24% | 79.41% | |||
| Normalized Basic EPS | -500.00% | 77.46% | |||
| EPS Diluted | -495.24% | 79.41% | |||
| Normalized Diluted EPS | -500.00% | 77.46% | |||
| Average Basic Shares Outstanding | 65.96% | 0.00% | |||
| Average Diluted Shares Outstanding | 65.96% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||